Few studies have objectively examined the relationship between depression and various stages of sexual function. Here we associate depression and sexual function using validated questionnaires. A retrospective review of 186 men was performed; demographics and serum hormone levels were obtained. Responses to questionnaires evaluating depressive symptoms (Patient Health Questionnaire (PHQ-9)), sexual function (International Index of Erectile Function (IIEF)) and hypogonadal symptoms (quantitative Androgen Decline in the Aging Male (qADAM)) completed by each patient were correlated using Spearman's rank correlation. Mean ± s.d. subject age: 52.6 ± 12.7 years; mean serum hormone levels: TT 429.8 ± 239.2 ng dl À 1 , free testosterone 9.72±7.5 pg ml À 1 and estradiol 34.4±22.8 pg ml À 1 . Negative correlations were observed between total PHQ-9 score and the sexual desire (r ¼ À 0.210, P ¼ 0.006), intercourse satisfaction (r ¼ À 0.293, Po0.0001) and overall satisfaction (r ¼ À 0.413, Po0.0001) domains of the IIEF and individual IIEF questions pertaining to erectile function. Men with a PHQ-9 score X10 (mild depression or worse), had lower sexual desire and sex life satisfaction. A negative correlation between PHQ-9 score and qADAM score (r ¼ À 0.634, Po0.0001) was observed and men with higher PHQ-9 score had lower qADAM scores. Depressive symptoms in men correlate with both psychological as well as physical aspects of sexual function.
INTRODUCTION
Studies have demonstrated numerous health benefits of sexual expression and satisfaction, including improvements in physical, emotional, mental and social health. Rosen et al.
1 studied the effects of erectile dysfunction (ED) therapy on family and overall life satisfaction, and found that sexual expression is an integral part of a lasting, healthy relationship, boosting self-esteem and improving intimacy. Additional studies have demonstrated a relationship between sexual dysfunction and age, cardiovascular disease, hypertension, diabetes and lower urinary tract symptoms. [2] [3] [4] [5] Sexual dysfunction, which includes sexual desire disorders, ED, ejaculation difficulties and anorgasmia, is associated with psychosocial problems including decreased quality of life, low self-esteem and anxiety. 3, [6] [7] [8] This association between sexual dysfunction and psychosocial problems is bidirectional and further complicated by the sexual side effects of antidepressants. Latini et al. 6 reported a strong relationship between severe ED and broad range of psychosocial domains. Problems with erections have been found to affect men in both their intimate and nonintimate life including how they see themselves as sexual beings. 9 Additionally, sexual function is related to a man's androgen status, with hypogonadal men having an increased incidence of ED. [10] [11] [12] Thus, sexual dysfunction in men with psychosocial issues likely has a profound impact on their quality of life. While depressive symptoms are associated with male sexual dysfunction, few studies exist examining the impact of depression on sexual function, or vice versa, in an objective manner. 3, 13 Litwin et al. examined health-related quality of life using the RAND 36-Item Health Survey (SF-36) questionnaire in 57 men with ED and observed a more significant effect on the emotional than the physical domains. The SF-36 is a validated, self-administered questionnaire that addresses eight domains of quality of life, including physical function, general health perception and emotional wellbeing. Comparably, Feldman et al. 2 used the results of the Massachusetts Male Aging Study (MMAS), a cross-sectional community-based random-sample survey of 1265 men aged between 40-70 years, to demonstrate that ED is directly correlated with anger and depression. Araujo et al. 14, 15 used the MMAS to show that men with ED were almost twice as likely to be depressed as their potent counterparts. These authors utilized the Center for Epidemiological Studies-Depression (CES-D) scale, a validated self-reporting scale, to assess depressive symptoms and the un-validated Sexual Activity Questions Related To Potency survey to assess ED, which did not permit evaluation of specific domains of sexual function. Two studies from the Johns Hopkins Sexual Behaviors Consultation Unit, examining patients with ED between 1976 and 1979 (n ¼ 199) and 1984 and 1986 (n ¼ 223), showed a high frequency of depressive symptoms and high scores on measures of psychological distress in patients with ED. 16, 17 Fagan et al. 17 , examined a cohort of 224 men with sex-related complaints or partners with sex-related complaints who were evaluated using DSM-III criteria for psychosexual dysfunction and found that men with ED had significant psychological distress as well as depressive and anxiety symptoms. However, this study did not relate the psychological or physical aspects of sexual function to depressive symptoms. Mathew et al. 18 studied sexual dysfunction in a group of 51 depressed patients using the Beck Rating Scale for Depression and an un-validated 0-7 scale assessing sexual dysfunction and showed that depressed patients were more likely to have altered libido than controls, but showed no relationship between depression and the physical aspects of sexual function. Several other studies have similarly linked sexual function and depression, primarily identifying correlations between the psychological aspects of sexual function, such as sexual desire and depression, without finding a relationship between the physical aspects of sexual function including the ability to have and maintain an erection, have an orgasm or ejaculate and depressive symptoms. 14, 16, 17 Despite the above insights, few studies have examined the relationship between sexual function and depressive symptoms using validated metrics. 2, 8, 16, 19, 20 In light of the dearth of objective data evaluating the intersection between the physical and psychological aspects of sexual function and depression, we evaluated this relationship using validated questionnaires.
MATERIALS AND METHODS

Patient selection and data collection
A retrospective review of 186 men presenting to our urology clinic between May and November 2011 was performed. After obtaining institutional review board approval, we obtained demographic information, including age, body mass index (BMI) and comorbidities. Each patient was asked to complete validated questionnaires evaluating depressive symptoms (Patient Health Questionnaire (PHQ-9)), sexual function (International Index of Erectile Function (IIEF)) and hypogonadism (both the quantitative Androgen Decline in the Aging Male (qADAM) and the ADAM). Each of the above questionnaires were completed once by each patient, and serum hormone levels, including total testosterone (TT), free T and estradiol were recorded for each patient at the time of questionnaire completion. We utilized the qADAM questionnaire preferentially to assess hypogonadal symptoms as it uses a 1-5 Likert scale that permits quantitation of the severity of hypogonadal symptoms, rather than simply a binary assessment as is the case with the ADAM, potentially providing increased sensitivity over the ADAM in evaluation of hypogonadal symptoms. 21 The qADAM questionnaire is composed of the same 10 questions as the validated ADAM questionnaire. However, the qADAM questionnaire uses scalar rather than binary responses, permitting evaluation of the severity of hypogonadal symptoms. Although not validated, the qADAM questionnaire correlates with serum T levels as well as other validated instruments of sexual function and hormonal status including the Expanded Prostate Cancer Index Composite and Sexual Health in Men questionnaires. 21 The IIEF questionnaire is comprised of 15 questions (see Table 2 
Data analysis
Spearman's rank correlation analysis was performed to assess the relationships between depressive symptoms and sexual function, as well as between depressive and hypogonadal symptoms, using comparisons between PHQ-9 and IIEF total scores as well as between PHQ-9 and qADAM total scores, respectively. We also assessed the correlations between PHQ-9 total score and individual IIEF and qADAM question scores, as well as between PHQ-9 total score and the domains of the IIEF. We also grouped men according to a PHQ-9 score cutoff of 10 and performed Spearman's rank correlation analysis within these groups as above. A PHQ-9 score X10 correlates with symptoms of at least mild depression. Finally, to assess which patients were likely to have more severe depressive symptoms, we used PHQ-9 questionnaire data to group patients using DSM-IV diagnostic criteria for major depressive disorder (MDD): five or more depressive symptoms (depressed mood, anhedonia, change in appetite, feelings of worthlessness or guilt, insomnia or hypersomnia, diminished concentration, psychomotor agitation or retardation, loss of energy, suicidal thoughts) having been present during the same 2-week period and representing a change from previous functioning, with at least one of the symptoms being depressed mood or loss of interest or pleasure. 22 We then compared IIEF domain and qADAM scores between these groups.
Data were analyzed using Microsoft Excel (Microsoft, Redmond, WA, USA) and SPSS (IBM Corp, Somers, NY, USA). Statistical analyses included Spearman's rank correlation to perform comparisons between questionnaire responses as above. Analysis of variance was used to compare numeric variables that were not related to questionnaires, and w 2 analysis to compare categorical variables. Statistical significance was considered at a P-value p0.01.
RESULTS
Between May and November 2011, 186 men receiving treatment at our clinic were included in the study. For all subjects, mean±s.d. subject age was 52.6±12.7 years and baseline serum hormone levels were: TT 429.8 ± 239.2 ng dl À 1 , free T 9.72 ± 7.5 pg ml À 1 and estradiol 34.4 ± 22.8 pg ml À 1 (Table 1) . A PHQ-9 score of X10 correlates with mild depression or worse, and in our cohort 30 of 186 (16.1%) men met this criterion, a rate similar to that previously observed in men in the general population. 23, 24 The relationship between depression and sexual function Significant negative correlations were observed between total PHQ-9 score and several domains of the IIEF, including sexual desire (r ¼ À 0.210,
.0001) and overall satisfaction (r ¼ À 0.413, Po0.0001) ( Table 2) . A negative correlation approaching significance was observed between PHQ-9 scores and the erectile function domain of the IIEF (r ¼ À 0.128, P ¼ 0.089). In addition, each individual question of the sexual desire (questions 11 and 12), intercourse satisfaction (questions 6, 7 and 8) and overall satisfaction (questions 13 and 14) domains of the IIEF showed significant negative correlation with the PHQ-9 score as well, as did one question of the erectile function domain (question 5). Men with a PHQ-9 score X10 had lower IIEF sex life satisfaction question scores (2.9 ± 1.3 (PHQ-9o10) vs 2.3 ± 1.0 (PHQ-9 X10), P ¼ 0.009) than men with PHQ-9 score X10 (Table 3 ). In addition, a significant difference in IIEF overall satisfaction domain was observed between groups (6.1±2.7 (PHQo10) versus 4.6±2.1 (PHQ X10), P ¼ 0.008). These data suggest that men with more significant depressive symptoms are more likely to have sexual dysfunction affecting the psychological domains of the IIEF, but also with an impact on the physical aspects of sexuality, including how often one is able to have an erection and the ability to maintain an erection.
The relationship between depression and hypogonadal symptoms We also evaluated the relationship between depressive and hypogonadal symptoms, as hypogonadism is associated with decreased libido, worsened erectile function and depressive symptoms. 10, 15, [25] [26] [27] Towards this goal, we correlated PHQ-9 scores with qADAM scores and observed strong negative correlations between total PHQ-9 score and individual qADAM questions 1-5, 7 and 9 (Table 4) . Furthermore, all individual PHQ-9 questions evidenced strong negative correlations with total qADAM score (Po0.0001 for each PHQ-9 question (Table 5) ) and men with a PHQ-9 score of X10 had lower mean qADAM scores than men with PHQ-9 o10 (19.1 ± 4.9 versus 26.0 ± 4.9, respectively, Po0.0001) ( Table 3) . Taken together, these data are in line with prior findings showing a relationship between depressive symptoms and hypogonadal symptoms. 12, 13, 27 It is important to note that we used qADAM scores to assess severity of hypogonadal symptoms. However, within our cohort, ADAM positivity was associated with lower mean qADAM score (Mean qADAM 24.2 in ADAM positive subgroup versus mean qADAM 28.4 in ADAM negative subgroup, Po0.001). As questions 2, 3, 4 and 5 on the qADAM questionnaire assess depressive symptoms the strong correlation between these individual questions and PHQ-9 questions is expected. While non-specific, given the overall eugonadal status of our patient population based on mean serum hormone levels, these data suggest that we were evaluating depressive symptoms that were less likely to be related to hormonal status, and more likely to be related to other causes. Of note, however, 41 of 73 (56.2%) men in the TT o300 and 61 of 112 (55.3%) of men in the in TT X300 group were already on T replacement therapy at the time of questionnaire completion.
Next, we grouped men using criteria for MDD (see Materials and methods) and compared IIEF domain and qADAM scores within these groups in order to evaluate the relationship between sexual function and more severe depressive symptoms. We observed significantly lower scores for the erectile function, sexual desire and overall satisfaction domains of the IIEF as well as total qADAM score in patients with symptoms consistent with MDD (Table 6 ). When using more stringent criteria for the presence of depression, we observed a greater difference between the MDD and no MDD subgroups in each IIEF domain except for the intercourse satisfaction and orgasmic function domain. For example, the difference in the erectile function domain scores between MDD and no MDD subgroups was much more significant when compared with the difference between PHQ-9 score subgroups (19.1±10.4 (PHQ-9o10) versus 17.5±10.3 (PHQ-9 X10) (P ¼ 0.443) and 19.4 ± 10.1 (no MDD) versus 14.1 ± 11.3 (MDD) (P ¼ 0.027)). These data suggest a positive relationship between the severity of sexual dysfunction and severity of depressive symptoms, and indicate that the physical aspects of sexual function may be more significantly impacted with more severe depressive symptoms. Abbreviations: BMI, body mass index; ED, erectile dysfunction; IIEF, The International Index of Erectile Function; PHQ-9, The Patient Health Questionnaire-9; qADAM, quantitative androgen deficiency in the aging male; T, testosterone. P-value refers to comparison between the PHQ-9 o10 and PHQ-9 X10 subgroups. 
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Effects of serum T and BMI on sexual function and hypogonadal symptoms The diagnosis of hypogonadism is made using both clinical evaluation for hypogonadal symptoms as well as evaluation of serum TT levels, with a TT of 300 ng dl À 1 frequently used as the cutoff between eugonadal and hypogonadal. In order to evaluate the impact of serum TT levels and BMI on IIEF and qADAM scores, we grouped men based on a serum TT cutoff of 300 ng dl À 1 and a BMI cutoff of 25 and observed lower total qADAM scores in men with TT X300 ng dl À 1 as well as men with BMI X25 kg m À 2 , but no significant differences in IIEF scores between these groups ( Table 7 ). Given that higher qADAM scores were found in eugonadal men, in contrast to what might be expected, we examined the frequency of positive ADAM scores in these subgroups and found that ADAM was positive in 61 of 73 (83.6%) of men in the TT o300 group and 90 of 112 (80.4%) men in the TT X300 group (P ¼ 0.815). However, no differences in qADAM scores were identified between subgroups when stratified based on whether men were on T replacement (data not shown).
DISCUSSION
Current evidence indicates that sexual dysfunction and depression frequently coexist. 15, [25] [26] [27] Given that the symptoms of hypogonadism can mimic depressive symptoms, and the presence of hypogonadism is associated with worse sexual function, one would expect depression and sexual function to correlate. 13, 27 However, the details of the relationship between sexual function and depression in men have been incompletely elucidated.
We evaluated the relationship between sexual dysfunction and depression in men by determining the correlations between validated questionnaires commonly used to assess the severity of depressive symptoms and sexual function. Our findings demonstrate a relationship between depressive symptoms and Importantly, the prevalence of MDD, as well as its severity, in our cohort is similar to that previously reported in male adults in the US. 24 When comparing depressive and hypogonadal symptoms using the PHQ-9 and qADAM questionnaires, we demonstrate significant correlations between these conditions, echoing prior findings in the literature. 2, 8, 28, 29 Furthermore, T replacement has been shown to improve depressive symptoms in hypogonadal men. [30] [31] [32] Obesity also affects sexual function and obese men are more likely to be hypogonadal. 33 Our data corroborate these findings overall, indicating that men with higher BMI are more likely to have both hypogonadal as well as depressive symptoms. When evaluating sexual function and hypogonadal symptoms using a common threshold for hypogonadal TT levels, we find that men with higher TT are more likely to have slightly lower scores on the qADAM questionnaire than men with lower TT. However, the difference in scores, while statistically significant, is small and the clinical significance unclear. In addition, no differences between the TT groups were observed when comparing ADAM positivity rates or when men were separated based on whether they were on T replacement.
Our study is limited by several factors. First, the size of our cohort is relatively small, encompassing only 186 men. Nevertheless, we were able to demonstrate a significant relationship between depression and sexual function using this cohort. Furthermore, we demonstrate a correlation between the physical aspects of sexual function and depressive symptoms for the first time, and show that this relationship relates to the severity of depressive symptoms. Second, our cohort is derived from men presenting to a urology clinic specializing in male sexual function and hypogonadism. Despite the finding that the rates of depression in our cohort mimic those of the general male population, the data from this study may not be generalizable, considering that 135 of 186 (72.6%) men in the cohort had hypogonadism and 115 of 186 (61.8%) had ED, rates higher than those of the general population. 2, [34] [35] [36] In addition, at the time of study, patients with ED and hypogonadism were receiving a variety of treatments for these conditions, which may further confound our findings (treatment data not reported). Third, we utilized the qADAM questionnaire, an unvalidated metric, for assessing hypogonadal symptoms. However, our findings using the qADAM were in line with those previously described and correlate appropriately with ADAM responses within the same cohort. Furthermore, the use of the binary responses ascertained using the ADAM questionnaire would not have permitted the fidelity attained using a numeric scale. Fourth, we present data for a single set of questionnaires completed by each subject, which does not permit trending of symptoms over time. Therefore, we cannot evaluate the effects of treatment for ED and hypogonadism in the population on questionnaire responses, which would further support the findings. It is important to note that successful ED treatment has been shown to significantly improve health related quality of life, and the effects of ED treatment within our cohort are unclear. 37 Finally, we grouped men with MDD using criteria available solely from each patient's responses on the PHQ-9 questionnaire rather than formal psychiatric evaluation, which may not reflect the true rate of depression in our cohort. However, as may be expected, men with more severe depressive symptoms did evidence worse sexual function.
CONCLUSION
Sexual dysfunction and depression are two common conditions in men that contribute to decreased quality of life. We demonstrate that these conditions are correlated, that the presence of depressive symptoms is related to both the psychological as well as the physical aspects of sexual function, and that the severity of depressive symptoms is related to the degree of sexual dysfunction. Future work will further clarify the relationship between the various domains of sexual function and depressive symptoms. Depression and sexual dysfunction in men AW Pastuszak et al
